Difficulty: Medium
Average Score: 92%
Practice
Regarding drugs used in Parkinson's disease, which statement is true?
Correct answer
D
Rationale
The correct answer is D) Amantadine has anti-Parkinsonian effects and is administered at a dose of 100mg bd. Amantadine is an antiviral medication that also exhibits anti-Parkinsonian effects by increasing dopamine release and blocking its reuptake. It is typically administered at a dose of 100mg twice daily to manage symptoms of Parkinson's disease.
Option A is incorrect because Bromocriptine is not the first-line drug for treating Parkinson's disease in psychotic patients. Instead, atypical antipsychotics are commonly used in this population due to their efficacy and tolerability.
Option B is incorrect as only about 1-5% of Levodopa enters the brain unaltered. The majority of Levodopa is metabolized peripherally into dopamine before it reaches the brain, limiting its effectiveness.
Option C is incorrect as patients taking Selegiline for Parkinson's disease are not necessarily limited in what they can eat due to the tyramine reaction phenomenon. While dietary restrictions may be recommended with some MAO inhibitors, Selegiline at low doses is selective for MAO type B and does not typically require dietary modifications.
In an educational context, understanding the pharmacology of CNS drugs used in Parkinson's disease is crucial for healthcare professionals to provide optimal care to patients. Knowledge of the mechanisms of action, dosing regimens, and potential side effects of these medications is essential for safe and effective management of Parkinson's disease.
Option A is incorrect because Bromocriptine is not the first-line drug for treating Parkinson's disease in psychotic patients. Instead, atypical antipsychotics are commonly used in this population due to their efficacy and tolerability.
Option B is incorrect as only about 1-5% of Levodopa enters the brain unaltered. The majority of Levodopa is metabolized peripherally into dopamine before it reaches the brain, limiting its effectiveness.
Option C is incorrect as patients taking Selegiline for Parkinson's disease are not necessarily limited in what they can eat due to the tyramine reaction phenomenon. While dietary restrictions may be recommended with some MAO inhibitors, Selegiline at low doses is selective for MAO type B and does not typically require dietary modifications.
In an educational context, understanding the pharmacology of CNS drugs used in Parkinson's disease is crucial for healthcare professionals to provide optimal care to patients. Knowledge of the mechanisms of action, dosing regimens, and potential side effects of these medications is essential for safe and effective management of Parkinson's disease.